[Intraoral minor salivary gland tumors. Report of 296 cases (author's transl)].

abstract：:Hodgkin's and non-Hodgkin's lymphomas are frequent and represent a heterogenic group of haematologic diseases. Prognostic factors allow to classify patients into homogeneic risk groups, to adapt treatment proposal to disease's risk and, in some cases, to avoid over-treatment. For all lymphomas, the first step is to de...

journal_title：Bulletin du cancer

authors： Cuenca X,Xhaard A,Mounier N

更新日期：2009-04-01 00:00:00

abstract：:This study is devoted to the analysis of the surgical treatment of cancer of the uterine cervix, stage III. Three circumstances are evaluated: - Stage III with urinary disease the purpose of the surgical treatment is most often to save the renal function;--Recurrences after radiotherapy where surgery is the only poss...

journal_title：Bulletin du cancer

authors： Rochard F,Michel G,Castaigne D,Lacour J

更新日期：1980-01-01 00:00:00

abstract：:The registry of digestive tumors of the department of Cote-d'Or recorded between 1976 and 1982, among 1543 colorectal cancers, 142 cases (9.2%) diagnosed with acute obstruction. Distribution of the tumors along the large bowel was as follows: rectal cancers were rarely obstructive (3.8%) whereas it was a more common f...

journal_title：Bulletin du cancer

authors： Boutron MC,Faivre J,Rallier du Baty H,Meny B,Bedenne L,Hillon P,Klepping C

更新日期：1988-01-01 00:00:00

abstract：:The discovery of oncogenes and tumor suppressors has established the original concept of cancer development based on a cascade of spontaneously occurring somatic mutations. It is now well known that genomes of cancer cells are deeply rearranged and that these rearrangements have devastating consequences on their organ...

journal_title：Bulletin du cancer

authors： Theillet C

更新日期：2010-11-01 00:00:00

abstract：:Cerebral non Hodgkin's lymphomas (NHL) of immunocompetent patients are rare disease (1% of all NHL), but their incidence has been steadily increasing in the last 20 years. Most cerebral NHL are diffuse large cell NHL with a B phenotype. These tumors are most often localized in the central nervous system, the eye or me...

journal_title：Bulletin du cancer

authors： Blay JY

更新日期：1997-10-01 00:00:00

abstract：:In an attempt to harmonize clinical practices among French hematopoietic stem cell transplantation centers, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held its sixth annual workshop series in September 2015 in Lille. This event brought together practitioners from across the c...

journal_title：Bulletin du cancer

authors： Dubois V,Brignier A,Elsermans V,Gagne K,Kennel A,Pedron B,Picard C,Ravinet A,Varlet P,Cesbron A,Delbos F,Yakoub-Agha I,Loiseau P

更新日期：2016-11-01 00:00:00

abstract：:The objective of this study was to estimate the direct costs of invasive cervical cancer (ICC) management to the French national health insurance system the 1st year after ICC diagnosis. A retrospective survey was conducted in three centres in 2005, including 42 patients admitted for ICC between 2001-2003. Medical rec...

journal_title：Bulletin du cancer

authors： Arveux P,Bénard S,Bouée S,Lafuma A,Martin L,Cravello L,Rémy V,Breugelmans JG

更新日期：2007-02-01 00:00:00

abstract：INTRODUCTION:Adapted physical activity (APA) is recognized as an effective supportive care for asthenia and quality of life in oncology. Before an APA program was organized, the feasibility of such a program was evaluated among the patients. METHODS:Descriptive, prospective, semi-qualitative, single-center study over ...

journal_title：Bulletin du cancer

authors： Crespel C,Brami C,de Boissieu P,Mazza C,Chauvet K,Lemoine A,Gavlak B,Léandri C,Brasseur M,Bertin E,Bouché O

更新日期：2018-03-01 00:00:00

abstract：:From July 1987 to July 1988, 35 patients with non small cell lung cancer, stage IV, were included in a phase II trial (GLOT NPC 87/01). The treatment was as follows: cisplatin 50 mg/m2 day 1, vindesin 3 mg/m2 day 1, mitomycin 6 mg/m2 day 2, and bleomycin 15 mg/day, day 1 + 2 by continuous infusion. The evaluation for ...

journal_title：Bulletin du cancer

authors： Souquet PJ,Fournel P,Jorda M,Laennec E,Piperno D,Trillet V,Rebattu P,Bernard JP

更新日期：1993-01-01 00:00:00

abstract：PURPOSE:GemOx was defined as a D1-D2 schedule, based on preclinical data. In order to improve convenience for patients, we evaluated a simplified D1-D1 GemOx regimen (S-GemOx) in MPA. PATIENTS AND METHODS:Patients (pts) with MPA were 2:1 randomly assigned for first-line treatment to S-GemOx (gemcitabine 1,000 mg/m(2),...

journal_title：Bulletin du cancer

authors： Afchain P,Chibaudel B,Lledo G,Selle F,Bengrine-Lefevre L,Nguyen S,Paitel JF,Mineur L,Artru P,André T,Louvet C

更新日期：2009-05-01 00:00:00

abstract：:The biological behaviour of invasive carcinoma of the uterine cervix is not always predictable. It is therefore important to establish new biological markers which could be useful in determining a more reliable prognosis. We have analyzed the c-Ha-ras and c-myc proto-oncogenes in a large series (154 cases) of cervical...

journal_title：Bulletin du cancer

authors： Riou G,Sheng ZM,Zhou D,Lusinchi A,Le Doussal V,Barrois M

更新日期：1990-01-01 00:00:00

abstract：:Cells in spleens from tumor bearing animals were found to inhibit in vitro reactivity of lymphocytes to a variety of stimulants. These suppressor cells inhibited the stimulation of normal lymphocytes by mitogens : P.H.A.-Con A-L.P.S. They were adherent cells, bore immunoglobulins at their surface and did not bear the ...

journal_title：Bulletin du cancer

authors： Lespinats G,Poupon MF

更新日期：1976-04-01 00:00:00

abstract：:With the objective of improvement of quality in oncology, an assessment of chemotherapy practice in hospital pharmacies in public and private hospitals was carried out by the regional committee of oncology in Lorraine. The 36 hospitals reporting using chemotherapy, had varied practices. The results of this survey lead...

journal_title：Bulletin du cancer

authors： May I,Paulus C,Vigneron J,Watelet M,Veyrier B,Bichet F,Bideaux S,Bey P

更新日期：2001-04-01 00:00:00

abstract：INTRODUCTION:The diagnosis of chronic myeloid leukemia is based on the presence of translocation t(9,22). Additional cytogenetic abnormalities may exist at diagnosis and have prognostic value. The authors evaluated the relationship between these additional chromosomal abnormalities, clinical presentation, and therapeut...

journal_title：Bulletin du cancer

authors： Silué DA,Kouakou B,Nanho CD,Kamara I,Djoko S,Sowhe T,Meité N,Ayemou R,Emeuraude N,Tolo A,Koffi G,Sanogo I

更新日期：2019-06-01 00:00:00

abstract：:Targeted therapy against the EGF receptor was shown to be effective in a subgroup of patients with KRAS wild-type colorectal cancer. Therefore, cetuximab (Erbitux) or panitumumab (Vectibix) obtained the authorization by the EMEA restricted to patients with KRAS wild-type tumours. KRAS mutational testing has become par...

journal_title：Bulletin du cancer

authors： Blons H,Laurent-Puig P

更新日期：2009-12-01 00:00:00

abstract：:Theoretical teaching of oncology was improved, 15 years ago, by individualizing a special university course during medical studies in France. However medical students need also practical exercising by relation with cancer patients. The main goals may be defined and given to students at the beginning of practical cours...

journal_title：Bulletin du cancer

authors： Hoerni B,Vrousos C

更新日期：1985-01-01 00:00:00

abstract：:The 4 year results of a prospective clinical trial on the treatment of operable breast cancer, comparing the effects of preoperative radiotherapy followed by surgery with those of surgery followed or not by postoperative radiotherapy are presented for patient groups of approximately 100 each. At 4 years 85 per cent su...

journal_title：Bulletin du cancer

authors： Wallgren A,de Schryver A,Wasserman J

更新日期：1977-01-01 00:00:00

abstract：:The epithelial-mesenchymal transition (EMT) is a morphogenetic program that converts epithelial into mesenchymal cells during the embryonic development. This mechanism is frequently reactivated during tumor progression and provides cells with motility and invasive capabilities favoring the metastatic dissemination fro...

journal_title：Bulletin du cancer

authors： Ansieau S,Caron de Fromentel C,Bastid J,Morel AP,Puisieux A

更新日期：2010-01-01 00:00:00

abstract：:This work examines the impact of the SARS-CoV2 epidemic and the organizational recommendations that have been issued since March 16 on tumor boards (TB) activity. The tumor board activity was measured from tumor board sheets extracted from the oncologic electronic file between January 7, 2019 and April 24, 2020. The p...

journal_title：Bulletin du cancer

authors： Grosclaude P,Azria D,Guimbaud R,Thibault S,Daubisse-Marliac L,Cartron G,Renaudie MJ,Dalbies PA,Delord JP,Bauvin E

更新日期：2020-01-01 00:00:00

abstract：:Thirty-two patients with high risk melanoma (either primary melanoma of the limbs or trunk, or recurrent melanoma) and clinically disease-free following appropriate surgical treatment were immunized with a vaccinia virus oncolysate made from a pool of 4 human melanoma cell lines. Injections were given id weekly for 3 ...

journal_title：Bulletin du cancer

authors： Doré JF,Portoukalian J,Berthier-Vergnes O,Jacubovich R,Genève J,Bailly M,Lefthériotis E,Weissbrod A,Mayer M

更新日期：1990-01-01 00:00:00

abstract：:At the time of diagnosis, central nervous system (CNS) involvement is identified in less than 10% of adult acute lymphoblastic leukemia (ALL). Long-term disease-free survival can be achieved in these patients. CNS disease at presentation does not appear to be an independent poor prognostic factor. In CNS leukemia, inn...

journal_title：Bulletin du cancer

authors： Thomas X,Pavan L,Le QH

更新日期：2008-07-01 00:00:00

abstract：:During the last decade, inhibitors of the vascular endothelial growth factor (VEGF) were developed for the treatment of cancer. Many anti-VEGF are available but the issue is still the same: to inhibit the effect of the VEGF on their receptors. There are two main classes, depending on the mechanism of action by blockin...

journal_title：Bulletin du cancer

authors： Deray G,Janus N,Aloy B,Launay-Vacher V

更新日期：2016-07-01 00:00:00

abstract：:Distinct clinicopathologic acute lymphoblastic leukemia (ALL) entities have been identified, resulting in the adoption of risk-oriented treatment approaches. In Philadelphia chromosome-positive (Ph(+)) ALL, the optimal treatment requires the addition of BCR-ABL tyrosine kinase inhibitors, as imatinib. However, the out...

journal_title：Bulletin du cancer

authors： Thomas X

更新日期：2011-07-01 00:00:00

abstract：:Gemtuzumab ozogamicin (GO) is a humanized monoclonal antibody anti-CD33 conjugated with calicheamicin and was indicated for acute myeloid leukemia (AML) patients. It was initially approved in 2000 by FDA thank to promising results from a phase II trial including elderly relapsing AML patients. Numerous studies evaluat...

journal_title：Bulletin du cancer

authors： Brotelle T,Lemal R,Moluçon-Chabrot C,Bay JO,Delaunay J,Guièze R

更新日期：2014-02-01 00:00:00

abstract：:Genomic DNA displays a non canonical structure prone to be damaged and modified by genotoxic stresses, which are induced either by the endogenous metabolism or attacks from environment or therapeutic pressure. Several molecular pathways allow cells to repair such DNA lesions. Additional mechanisms have been selected t...

journal_title：Bulletin du cancer

authors： Cazaux C

更新日期：2010-11-01 00:00:00

abstract：UNLABELLED:This CORCAN study is concerned with the way patients hospitalised for peritoneal carcinosis perceive surgical treatment and hyperthermic intraperitoneal chemotherapy (HIPEC). OBJECTIVES:(1) To identify and analyse, using concepts of social representation and accounts of the illness, characteristics of the w...

journal_title：Bulletin du cancer

authors： Durif-Bruckert C,Guilloux R,Guïoux A,Lasserre E,Goffette J,Régnier V

更新日期：2016-02-01 00:00:00

abstract：:Malnutrition is common in oncology. However, it is often detected too late and nutritional support is sub-optimal. The patient's opinion, although often sought in therapeutic decisions in oncology, does not appear to be frequently taken into account in dietetic management. In NutriCancer2012 study, we interviewed pati...

journal_title：Bulletin du cancer

authors： Raynard B,Hébuterne X,Goldwasser F,Ait Hssain A,Dubray Longeras P,Barthélémy P,Rosso E,Phoutthasang V,Bories C,Digue L,Laharie D,Desport JC,Falkowski S,Lacau Saint Guily J,Gyan E

更新日期：2017-11-01 00:00:00

abstract：:Alveolar soft part sarcoma, ASPS, is a rare malignant tumor, with preferential primary localization in limbs, usually occurring in adolescents and young adults. This sarcoma, well defined histologically and at molecular level, has an indolent course, but a high potential metastatic pulmonary and cerebral evolution, so...

journal_title：Bulletin du cancer

authors： Paillard C,Coulomb A,Helfre S,Orbach D

更新日期：2015-09-01 00:00:00

abstract：:Hypoxic cell fraction was measured in a human tumour xenografted on two different animal species: mouse and rat. These results suggest that, while the Na11 tumour response to radiation depends on the host (nude mouse, nude rat), the proportion of hypoxic cells tested with the growth delay assay is independent of the h...

journal_title：Bulletin du cancer

authors： Guichard M,Chavaudra N,Malaise EP

更新日期：1989-01-01 00:00:00

abstract：:Neoadjuvant chemoradiotherapy is considered at the present time as the standard treatment of most T3-4 rectal cancer. In France a combination of radiotherapy (45 Gy/5 weeks) with concurrent capecitabine (1,600 mg/m2) is the most popular protocol. Randomized trials try to optimize this approach using new cytotoxic drug...

journal_title：Bulletin du cancer

authors： Gérard JP,Francois E,Deustch E,Rostom Y,Douar N,Benezery K,Milano G

更新日期：2009-03-01 00:00:00